fluorodeoxyglucose f18 has been researched along with Brown Tendon Sheath Syndrome in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diamond, T; Kumar, S | 1 |
Amtage, F; Hellwig, S; Kreft, A; Maurer, C; Meyer, PT; Rijntjes, M; Tüscher, O; Weiller, C; Winkler, C | 1 |
Castelnovo, G; Collombier, L; Labauge, P; Renard, D | 1 |
Newey, CR; Sarwal, A; Wu, G | 1 |
Chen, CL; Chen, CM; Chou, HH; Shen, CY; Tsai, SJ | 1 |
Bartenstein, P; Brandt, T; Danek, A; Dieterich, M; Minoshima, S; Schwaiger, M; Weindl, A; Wenzel, R; Ziegler, S | 1 |
Inoue, C; Ishii, K; Kawasaki, T; Kiyosawa, M; Senda, M | 1 |
de Jong, BM; Haaxma, R; van Weerden, TW | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Brown Tendon Sheath Syndrome
Article | Year |
---|---|
Post-infectious opsoclonus and reversible magnetic resonance imaging changes: a case report and review of the literatures.
Topics: Acyclovir; Aged; Antiviral Agents; Brain; Central Nervous System Viral Diseases; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Ocular Motility Disorders; Positron-Emission Tomography | 2012 |
7 other study(ies) available for fluorodeoxyglucose f18 and Brown Tendon Sheath Syndrome
Article | Year |
---|---|
Paraneoplastic syndrome - a rare but treatable cause of non-thyroid-related extraocular muscle enlargement.
Topics: Aged; Antigens, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Diplopia; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Hypertrophy; Letrozole; Magnetic Resonance Imaging; Ocular Motility Disorders; Oculomotor Muscles; Paraneoplastic Syndromes; Piperazines; Positron-Emission Tomography; Prednisone; Pyridines | 2019 |
Functional correlates of vertical gaze palsy and other ocular motor deficits in PSP: an FDG-PET study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Ocular Motility Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive | 2014 |
Teaching NeuroImages: FDG-PET in progressive supranuclear palsy.
Topics: Accidental Falls; Aged; Atrophy; Biomarkers; Brain; Deglutition Disorders; Diagnosis, Differential; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Mesencephalon; Ocular Motility Disorders; Personality Disorders; Positron-Emission Tomography; Predictive Value of Tests; Supranuclear Palsy, Progressive | 2010 |
Radiological correlate of ocular flutter in a case with paraneoplastic encephalitis.
Topics: Cerebellar Ataxia; Diagnosis, Differential; Encephalitis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Ocular Motility Disorders; Paraneoplastic Syndromes, Nervous System; Paraneoplastic Syndromes, Ocular; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms | 2013 |
Deactivation of human visual cortex during involuntary ocular oscillations. A PET activation study.
Topics: Adult; Aged; Blood Flow Velocity; Cerebrovascular Circulation; Cold Temperature; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nystagmus, Physiologic; Ocular Motility Disorders; Physical Stimulation; Regional Blood Flow; Tomography, Emission-Computed; Vestibule, Labyrinth; Visual Cortex; Water | 1996 |
Positron emission tomography in diagnosing brainstem vascular lesions that cause abnormal eye movements.
Topics: Adult; Aged; Brain; Brain Stem; Cerebral Infarction; Deoxyglucose; Eye Movements; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Ocular Motility Disorders; Tomography, Emission-Computed | 1996 |
Opsoclonus-induced occipital deactivation with a region-specific distribution.
Topics: Brain Mapping; Case-Control Studies; Fluorodeoxyglucose F18; Humans; Motion Perception; Occipital Lobe; Ocular Motility Disorders; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |